Showing results (61-70 of 102) with videos related to
Sort By:
Pageof 11
Journal of Cardiovascular Pharmacology|August 18, 2017
Levosimendan in Acute and Advanced Heart Failure: An Appraisal of the Clinical Database and Evaluation of Its Therapeutic ApplicationsJohann Altenberger, Finn Gustafsson, Veli-Pekka Harjola, et al.Journal of the American Heart Association|October 30, 2018
Differential Effects of Levosimendan and Dobutamine on Glomerular Filtration Rate in Patients With Heart Failure and Renal Impairment:A Randomized Double-Blind Controlled TrialLukas Lannemyr, Sven-Erik Ricksten, Bengt Rundqvist, et al.Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|January 27, 2021
Incidental cardiac findings on somatostatin receptor PET/CT: What do they indicate and are they of clinical relevance?Emanuele Bobbio, Anna Dudás, Anders Bergström, et al.Viruses|February 24, 2024
COVID-19 Outcomes and Vaccinations in Swedish Solid Organ Transplant Recipients 2020-2021: A Nationwide Multi-Register Comparative Cohort StudyJohn Mackay Søfteland, Huiqi Li, Jesper M Magnusson, et al.Clinical Transplantation|May 24, 2020
Cholesterol lowering with EVOLocumab to prevent cardiac allograft Vasculopathy in De-novo heart transplant recipients: Design of the randomized controlled EVOLVD trialKaspar Broch, Einar Gude, Kristjan Karason, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 22, 2024
Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trialEntela Bollano, Arne K Andreassen, Hans Eiskjaer, et al.Clinical Transplantation|June 23, 2017
Effect of everolimus vs calcineurin inhibitors on quality of life in heart transplant recipients during a 3-year follow-up: Results of a randomized controlled trial (SCHEDULE)Anne Relbo Authen, Ingelin Grov, Kristjan Karason, et al.ESC Heart Failure|February 15, 2020
Invasive haemodynamics in de novo everolimus vs. calcineurin inhibitor heart transplant recipientsNiklas Bergh, Einar Gude, Sven-Erik Bartfay, et al.Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 9, 2022
Subtyping of cardiac amyloidosis by mass spectrometry-based proteomics of endomyocardial biopsiesFredrik Noborn, Christer Thomsen, Egor Vorontsov, et al.Iscience|July 12, 2026
A journey through the molecular networks of endomyocardial biopsies to explore ATTR and AL<i>λ</i> cardiac amyloidosisRaffaello Viganò, Andrea Lomagno, Fredrik Noborn, et al.Pageof 11